title: Prophylactic use of interferon alfa after bone marrow transplantation for patients with chronic myelogenous leukemia at high risk of relapse: a pilot study. The Chronic Leukemia Working Party of the EBMT.
authors.affiliation: Department of Internal Medicine, University Hospital, Innsbruck, Austria.
authors.forename: D
authors.initials: D
authors.lastname: Niederwieser
authors.forename: W
authors.initials: W
authors.lastname: Arcese
authors.forename: G
authors.initials: G
authors.lastname: Bandini
authors.forename: H
authors.initials: H
authors.lastname: Schwaighofer
authors.forename: J
authors.initials: J
authors.lastname: Thaler
authors.forename: A
authors.initials: A
authors.lastname: Bosi
authors.forename: P
authors.initials: P
authors.lastname: Di Bartolomeo
authors.forename: E P
authors.initials: EP
authors.lastname: Alessandrino
authors.forename: C
authors.initials: C
authors.lastname: Urban
authors.forename: A
authors.initials: A
authors.lastname: Gratwohl
mesh_terms: D016026:Bone Marrow Transplantation / Q000009:adverse effects; D005240:Feasibility Studies; D006086:Graft vs Host Disease / Q000209:etiology; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000473:pathology / Q000628:therapy*; D010865:Pilot Projects; D012008:Recurrence
chemical_list: D016898:Interferon-alpha